☰

Mandana Manzari - Publications

Affiliations: 
Memorial Sloan Kettering Cancer Center, Rockville Centre, NY, United States 
Tree Info Similar researchers PubMed Report error

4 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Manzari MT, Shamay Y, Kiguchi H, Rosen N, Scaltriti M, Heller DA. Targeted drug delivery strategies for precision medicines. Nature Reviews. Materials. 6: 351-370. PMID 34950512 DOI: 10.1038/s41578-020-00269-6  0.343
2020 Bala Tannan N, Manzari MT, Herviou L, da Silva Ferreira M, Hagen CJ, Kiguchi H, Manova-Todorova K, Seshan VE, de Stanchina E, Heller DA, Younes A. Tumor Targeted Nanoparticles Improve Therapeutic Index of BCL2 and MCL1 dual inhibition. Blood. PMID 33067607 DOI: 10.1182/blood.2020008017  0.343
2019 Manzari MT, Anderson GR, Lin KH, Soderquist RS, Çakir M, Zhang M, Moore CE, Skelton RN, Fèvre M, Li X, Bellucci JJ, Wardell SE, Costa SA, Wood KC, Chilkoti A. Genomically informed small-molecule drugs overcome resistance to a sustained-release formulation of an engineered death receptor agonist in patient-derived tumor models. Science Advances. 5: eaaw9162. PMID 31517048 DOI: 10.1126/Sciadv.Aaw9162  0.437
2012 Spangler JB, Manzari MT, Rosalia EK, Chen TF, Wittrup KD. Triepitopic antibody fusions inhibit cetuximab-resistant BRAF and KRAS mutant tumors via EGFR signal repression. Journal of Molecular Biology. 422: 532-44. PMID 22706026 DOI: 10.1016/J.Jmb.2012.06.014  0.302
Show low-probability matches.